Stay updated on Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 label was added, replacing Revision: v3.6.3. This indicates a backend/content-management update rather than a change to the study data on the page.
    Difference
    0.0%
    Check dated 2026-07-28T15:40:23.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    A new site revision label (Revision: v3.6.3) appears, replacing the previous v3.6.0. This indicates a recent update to the page's underlying software or formatting.
    Difference
    0.0%
    Check dated 2026-06-30T00:40:32.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added an explicit recruitment-status note 'No longer looking for participants' and introduced several help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading formatting was updated, and the revision tag was bumped to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T18:15:28.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page's revision tag was updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a new build of the site metadata. This change does not alter visible content or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-06-08T15:26:38.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page revision shows v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page's versioning metadata rather than changes to study details.
    Difference
    0.0%
    Check dated 2026-05-18T03:54:00.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    This reflects a minor ClinicalTrials.gov site/UI release update (revision label changed to v3.5.3) without changing the study details themselves.
    Difference
    0.0%
    Check dated 2026-04-26T15:43:58.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.